The future of mental health treatment: Zelquistinel’s role
Drug Target Review
MARCH 17, 2025
Neuropsychiatric treatment is on the verge of a major transformation. Historically, treatment options have been limited, with patients relying on daily medications that have minimal efficacy and troublesome side effects. The drug’s pharmacokinetics (PK) and pharmacodynamics (PD) are closely linked.
Let's personalize your content